Jump to content [Access key 'm'] Jump to site navigation [Access key 'n'] Jump to Contact Us and Glossary [Access key 's'] Jump to Site Services and Sitemap [Access key 's'] Jump to local navigation [Access key 'l']
 

Investors

Press Releases

If you would like to be alerted when a press release is added to this site, please register with the Alerting Service.



 

10/15/2001 Cyclacel Provides Clinical Development Update On CYC202 CDK Inhibitor
10/08/2001 Cyclacel Receives US Patent On Novel Drug Target Of The Cancer Cell Cycle
06/14/2001 Cyclacel Completes £34 Million Private Placement
04/17/2001 Cyclacel And AstraZeneca Collaboration On CYC103 Genomics Drug Target
02/19/2001 Cyclacel Begins CYC202 Phase I Trial
01/31/2001 Investors In People Recognition For Cyclacel
01/31/2001 Former Celltech Research Head Joins Cyclacel As R&D Director
Go to top  Go to top    Print page (opens in a new window)  Print page
 
Copyright © 1997-2008 Cyclacel Pharmaceuticals, Inc. All Rights Reserved  |  Site Map  |  Privacy  |  Disclaimer  |  Contact Us  |  Alerting Service